Answers are grounded in this paper and cite their sources.
Validated prognostic, predictive, and toxicity markers should help cancer treatment move from the current trial-and-error approach to more personalized treatment.
No takes yet. Share an insight, caveat, or question.
Duffy et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: